Tech

Target choice

We prioritise genetic targets most likely to deliver significant health impact and prevent or change the course of disease. We can then develop treatments to address the underlying causes of the disease and prevent the disease from progressing.

For example, through analysis of genetic data we've found a connection between a protein involved in the immune system and a health condition. We are using this knowledge to develop potential treatments that may be able to provide relief to patients.

Patient identification

We use data and technology to understand which patients are likely to respond well to a treatment and benefit most at specific stages of the disease. This helps us to personalise treatments and improve outcomes for patients so they receive the most effective care, at the right time.

We are using this approach to help explore treatments in more patients with a range of conditions. By modelling retrospective data using AI/ML, we can see how different patients might respond.

Molecule design

Using platform tech like oligonucleotides, mRNA, small molecules and monoclonal antibodies, we design medicines and vaccines at the molecular level to target specific parts of a disease and ensure it can be manufactured consistently and as safely as possible.

For example, we are exploring how to use oligonucleotides to target specific proteins associated with liver disease.

Clinical trial effectiveness

Tech is making our clinical trials faster and more efficient, from design to data collection and patient recruitment. We use tools like AI to predict the best times and places to conduct trials and automate document submissions.

This speeds up the process, reduces costs, and helps deliver medicines to patients faster.

Smart manufacturing

We are revolutionising our supply chain utilising data, AI, machine learning, robotics, and automation to boost efficiency, product quality and capacity. For instance, we’re using digital twin models (“digital factories”) across several products to simulate processes, anticipate issues and accelerate manufacturing. By optimising our supply chain, we can ensure a steady supply of medicines and vaccines to patients worldwide.

Cultivating a tech-enabled culture

We empower our people to find solutions by cultivating a tech-enabled culture. We also automate and scale processes and tasks where tech can provide faster and more precise solutions. This frees up our talented workforce to focus on what they do best - solving complex problems using creativity, human judgement, and deep expertise.

Supporting the patient journey

Using data and technology, we aim to support the entire patient journey, from before patients are prescribed our vaccines and medicines to ongoing care management. One such example is our digital tool EasyVax, the first-ever vaccines scheduler in the US for all recommended adult immunisations (regardless of manufacturer) to improve vaccination rates and reduce preventable diseases. Using a QR code patients can schedule their vaccination appointment at a local pharmacy, from their smart phones. By providing opportunities for personalised care and effectively managing their health conditions patients can have more control of their health and well-being.